439 related articles for article (PubMed ID: 14730101)
1. Influence of classic and atypical neuroleptics on caffeine oxidation in rat liver microsomes.
Daniel WA; Kot M; Wójcikowski J
Pol J Pharmacol; 2003; 55(6):1055-61. PubMed ID: 14730101
[TBL] [Abstract][Full Text] [Related]
2. Effects of phenothiazine neuroleptics on the rate of caffeine demethylation and hydroxylation in the rat liver.
Daniel WA; Syrek M; Ryłko Z; Kot M
Pol J Pharmacol; 2001; 53(6):615-21. PubMed ID: 11985335
[TBL] [Abstract][Full Text] [Related]
3. Effects of classic and newer antidepressants on the oxidation pathways of caffeine in rat liver. In vitro study.
Daniel WA; Kot M; Wójcikowski J
Pol J Pharmacol; 2003; 55(6):1045-53. PubMed ID: 14730100
[TBL] [Abstract][Full Text] [Related]
4. Effects of antidepressant drugs on the activity of cytochrome P-450 measured by caffeine oxidation in rat liver microsomes.
Danie WA; Syrek M; Ryłko Z; Wójcikowski J
Pol J Pharmacol; 2001; 53(4):351-7. PubMed ID: 11990081
[TBL] [Abstract][Full Text] [Related]
5. Inhibition of rat liver CYP2D in vitro and after 1-day and long-term exposure to neuroleptics in vivo-possible involvement of different mechanisms.
Daniel WA; Haduch A; Wójcikowski J
Eur Neuropsychopharmacol; 2005 Jan; 15(1):103-10. PubMed ID: 15572279
[TBL] [Abstract][Full Text] [Related]
6. Relative contribution of rat cytochrome P450 isoforms to the metabolism of caffeine: the pathway and concentration dependence.
Kot M; Daniel WA
Biochem Pharmacol; 2008 Apr; 75(7):1538-49. PubMed ID: 18279840
[TBL] [Abstract][Full Text] [Related]
7. The contribution of cytochrome P-450 isoenzymes to the metabolism of phenothiazine neuroleptics.
Daniel WA; Syrek M; Haduch A
Eur Neuropsychopharmacol; 2002 Oct; 12(5):371-7. PubMed ID: 12208554
[TBL] [Abstract][Full Text] [Related]
8. Interactions between neuroleptics and CYP2C6 in rat liver--in vitro and ex vivo study.
Haduch A; Ogórka T; Boksa J; Daniel WA
Pharmacol Rep; 2005; 57(6):872-7. PubMed ID: 16382211
[TBL] [Abstract][Full Text] [Related]
9. Pharmacokinetics of phenothiazine neuroleptics after chronic coadministration of carbamazepine.
Daniel WA; Syrek M; Haduch A; Wójcikowski J
Pol J Pharmacol; 1998; 50(6):431-42. PubMed ID: 10385926
[TBL] [Abstract][Full Text] [Related]
10. The activity of cytochrome P450 CYP2B in rat liver during neuroleptic treatment.
Haduch A; Wójcikowski J; Daniel WA
Pharmacol Rep; 2007; 59(5):606-12. PubMed ID: 18048963
[TBL] [Abstract][Full Text] [Related]
11. Effects of selective cytochrome P-450 inhibitors on the metabolism of thioridazine. In vitro studies.
Daniel WA; Syrek M; Haduch A
Pol J Pharmacol; 1999; 51(5):435-42. PubMed ID: 10817545
[TBL] [Abstract][Full Text] [Related]
12. Metabolism of the antimammary cancer antiestrogenic agent tamoxifen. I. Cytochrome P-450-catalyzed N-demethylation and 4-hydroxylation.
Mani C; Gelboin HV; Park SS; Pearce R; Parkinson A; Kupfer D
Drug Metab Dispos; 1993; 21(4):645-56. PubMed ID: 8104124
[TBL] [Abstract][Full Text] [Related]
13. Main contribution of the cytochrome P450 isoenzyme 1A2 (CYP1A2) to N-demethylation and 5-sulfoxidation of the phenothiazine neuroleptic chlorpromazine in human liver--A comparison with other phenothiazines.
Wójcikowski J; Boksa J; Daniel WA
Biochem Pharmacol; 2010 Oct; 80(8):1252-9. PubMed ID: 20615392
[TBL] [Abstract][Full Text] [Related]
14. Quinolone inhibition of cytochrome P-450-dependent caffeine metabolism in human liver microsomes.
Fuhr U; Wolff T; Harder S; Schymanski P; Staib AH
Drug Metab Dispos; 1990; 18(6):1005-10. PubMed ID: 1981505
[TBL] [Abstract][Full Text] [Related]
15. Perazine at therapeutic drug concentrations inhibits human cytochrome P450 isoenzyme 1A2 (CYP1A2) and caffeine metabolism--an in vitro study.
Wójcikowski J; Daniel WA
Pharmacol Rep; 2009; 61(5):851-8. PubMed ID: 19904008
[TBL] [Abstract][Full Text] [Related]
16. Effect of carbamazepine on the pharmacokinetics of promazine.
Syrek M; Wójcikowski J; Daniel W
Pol J Pharmacol; 1996; 48(6):601-8. PubMed ID: 9112700
[TBL] [Abstract][Full Text] [Related]
17. Differential inhibition of rat and human hepatic cytochrome P450 by Andrographis paniculata extract and andrographolide.
Pekthong D; Martin H; Abadie C; Bonet A; Heyd B; Mantion G; Richert L
J Ethnopharmacol; 2008 Feb; 115(3):432-40. PubMed ID: 18053665
[TBL] [Abstract][Full Text] [Related]
18. Metabolism of the antidepressant mirtazapine in vitro: contribution of cytochromes P-450 1A2, 2D6, and 3A4.
Störmer E; von Moltke LL; Shader RI; Greenblatt DJ
Drug Metab Dispos; 2000 Oct; 28(10):1168-75. PubMed ID: 10997935
[TBL] [Abstract][Full Text] [Related]
19. Direct effects of neuroleptics on the activity of CYP2A in the liver of rats.
Haduch A; Wójcikowski J; Daniel WA
Pharmacol Rep; 2005; 57(6):867-71. PubMed ID: 16382210
[TBL] [Abstract][Full Text] [Related]
20. Contribution of human cytochrome p-450 isoforms to the metabolism of the simplest phenothiazine neuroleptic promazine.
Wójcikowski J; Pichard-Garcia L; Maurel P; Daniel WA
Br J Pharmacol; 2003 Apr; 138(8):1465-74. PubMed ID: 12721102
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]